1Life Healthcare, Inc.

The company's financials show resilient growth, with revenue advancing from $254.10M in Q1 2022 to $274.24M in Q4 2022. Gross profit remained healthy with margins at 18% in Q4 2022 compared to 19% in Q1 2022. Operating income hit -$111.52M last quarter, sustaining a consistent -41% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$86.32M. Net income rose to -$101.14M, while earnings per share reached -$0.49. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.